INTRODUCTION

153
In vitro RNA transcription and electroporation. Plasmids were purified by 154 centrifugation in CsCl gradients. Before the transcription reaction, they were linearized 155 with MluI. RNAs were synthesized by SP6 RNA polymerase in the presence of a cap 156 analog according to the manufacturer's recommendations (Invitrogen). The yield and 157 integrity of the transcripts was analyzed by gel electrophoresis under non-denaturing 158 conditions. Aliquots of transcription reactions were used for electroporation without 159 additional purification. Electroporation of BHK-21 cells was performed under previously 160 described conditions (23). Some of the rescued mutant viruses were unable to replicate to 161 infectious titers sufficient to infect cells in the subsequent experiments using a 162 multiplicity of infection (MOI) of >1 infectious unit (inf.u)/cell. Therefore, such defective 163 genomes were packaged into infectious virions to titers above 10 9 inf.u/ml by co-164 VEEV/chikvSD1/GFP and VEEV/eeevSD1/GFP) or 6 times (for VEEV/randSD1/GFP) 174 on BHK-21 cells. To select the most efficiently replicating, evolved variants, at each 175 9 passage, we infected using a ten-fold reduced volume of virus harvested from the 176 previous passage. Stocks demonstrating a more efficiently spreading infection were 177 plaqued on BHK-21 cells to confirm evolution to a large plaque-forming phenotype. For 178 each variant, several plaque-purified isolates were sequenced using VEEV-specific 179 primers. The identified putative adaptive mutations were cloned back into original 180 constructs, and rescued viruses were tested in terms of rates of infectious virus release, 181 titers and plaque size. harvested, clarified by centrifugation at 5,000 x g for 15 min and particles were 213 concentrated to ~1 ml using Amicon Ultra 100K centrifugal filters (Millipore). Viral 214 particles and VLPs were further purified by ultracentrifugation in discontinuous sucrose 215 gradients (15% / 40%) at 35,000 rpm in SW-55 rotor (Beckman) for 1 h at 4°C. Bands 216 containing virus particles were identified between the sucrose layers and used for EM 217 analysis. Droplets of virus suspension were placed onto a freshly glow-discharged, 400-218 mesh copper electron microscope grids covered with carbon film. Grids were blotted dry, 219
washed with water and stained with 1% uranyl acetate. Images were acquired at x80,000 220 magnification using a FEI Tecnai F20 electron microscope in the UAB cryo-EM facility. acids but in the wrong order (Fig. 1) . VEEV/eeevSD1/GFP exhibited higher replication 291 rates than VEEV/chikvSD1/GFP (Fig. 2B) , probably due to a higher sequence similarity 292 between EEEV SD1 and VEEV SD1. However, its replication remained less efficient 293 compared to the parental VEEV/GFP. 294
As the introduced modifications of SD1 could also have an impact on the amount 295 of capsid protein production during infection, we analyzed the accumulation of mutated 296 VEEV capsid proteins and glycoproteins in the infected cells (Fig. 3A) . The detected 297 small differences were insufficient to explain strong decreases in virus titers. 298
Our previously published data have demonstrated that modifications in SD1 affect 299 PFU:GE ratio (17). This negative effect, which characterizes particle infectivity, is 300 relatively small, within 4-fold, and does not explain a few orders of magnitude lower 301 infectious titers. Therefore, to show that extensive changes in SD1 had also a strong 302 negative effect on particle release, we directly analyzed their accumulation in the media 303 ( Capsid genes of the variants isolated from randomly selected plaques were 324 sequenced. As expected, no mutations were identified in VEEV/ΔSD1/GFP. 325 VEEV/chikvSD1/GFP contained two mutations in all plaque-purified variants. One was 326 located in the CHIKV-specific SD1 and the second was found in the VEEV SD2 (Helix 327 I) sequence (Fig. 4A) . Plaque-isolated variants of VEEV/eeevSD1/GFP contained a 328 single mutation in either SD1 or SD2 (Fig. 4B) . VEEV/randSD1/GFP was the least 329 capable variant in acquiring adaptive mutations. During serial passaging, its large plaque-330 forming variant appeared noticeably later than others, after 6 passages. The reason for its 331 slower adaptation was that in this case, a greater change in the capsid-coding sequence 332 was required (Fig. 4C) : a duplication of a 7-aa-long SD2 fragment, which most likely 333 extended the α-helix. 334
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To confirm the positive effects of the mutations, they were transferred into the 335 originally designed variants. The newly designed VEEV/chikvSD1ev/GFP, 336 VEEV/eeevSD1ev1/GFP, VEEV/eeevSD1ev2/GFP and VEEV/randSD1ev/GFP viruses 337 demonstrated 10-100-fold higher replication rates than the parental constructs (Fig. 4) . At 338 all times post infection, titers of the adapted variants were closer to those of VEEV/GFP. 339
Thus, in all of the selected second-site mutants, adaptation was associated with 340 additional direct modification of the amino terminal fragment of capsid protein in either 341 SD1 or SD2 domains. This was an indication that these two subdomains likely have 342 synergistic or additive functions in formation of infectious virions. The more efficient 343 particle release by cells infected with VEEV/randSD1ev/GFP (Fig. 3B) All of these variants were viable, and analysis of their replication rates 365 demonstrated that the presence of CHIKV SD2 in addition to SD1 in 366 VEEV/chikvSD12/GFP had readily detectable positive effect on virus replication rates 367 (Fig. 5B) . Further addition of CHIKV-specific SD3 did not cause a noticeable increase in 368 the rates of VEEV/chikvSD123/GFP virus release. Furthermore, VEEV with all four 369 CHIKV-derived capsid subdomains, VEEV/chikvSD1234/GFP, replicated less efficiently 370 than the original VEEV/GFP or variants containing two or three CHIKV-derived, 371 upstream-located subdomains (Fig. 5B) . In the infected cells, the newly designed capsid 372 proteins accumulated to similar levels (Fig. 5C) , suggesting that the difference in 373 infectious virus release was not a result of protein translation or stability. 374
The results of the previous study demonstrated that sequence of SD3 had no effect 375 on the efficiency of NC and virion formation, if this subdomain remained highly 376 positively charged (17). This observation suggested a plausible explanation as to why 377 replacement of VEEV SD3 with CHIKV SD3 in addition to the upstream-located capsid 378 subdomain substitutions had no stimulatory effect on the rates of infectious virus release. 379
The reduction in titers produced by SD4 replacement was likely the result of SD4's 380 (Fig. 6B and data not shown) , and released GFP-415 positive particles. They were released less efficiently than those formed by replicating 416 VEEV/GFP, but after concentration, were readily detectable under a confocal microscope 417 (Fig. 6C) . Their further analysis by EM revealed that they have an irregular structure, 418 different from icosahedral wt VEEV virions (Fig. 6D) . No particle release was detected 419 from cells infected with either VEErep/SD1-GFP-Cc, expressing no glycoproteins, or 420 VEEV/GFP-Cc, which encoded a GFP-Cc fusion that lacked the SD1 and SD2. Thus, 421 SD1 is playing an important role in particle assembly and budding, which becomes 422 particularly evident in the absence of other factors, such as RNA-capsid protein 423
interaction. 424
Next BHK-21 cells were infected with the designed constructs (Fig. 7A) at the 425 same MOI, and 3D images were acquired (Fig. 7B) Taken together, the data suggest that SD1 function is critical for assembly of 438 VEEV NC. It appears to be as important the virion budding at the plasma membrane as i) 439 lateral interactions between the carboxy terminal capsid's domains, which mediate 440 assembly of icosahedral NC, and ii) capsid interactions glycoprotein spikes, which drives 441 the envelope formation (Fig. 8) . 442
443
DISCUSSION 444
The data accumulated in the last few years strongly suggested that NC formation 445 during VEEV assembly is a complicated process, which is tightly regulated and 446 determined by more than specific interaction of capsid protein with the virus-specific PS 447 in the genomic RNA (17, 26, 27). The studies performed on different alphaviruses also 448 indicated the existence of two mechanisms in virion assembly. The first mechanism 449 suggests pre-formation of the nucleocapsids in the cytoplasm, followed by their migration 450 to the plasma membrane either by passive diffusion or at the surface of previously closely related NW alphavirus, EEEV, was more efficient in infectious virion release than 494 the SD1 sequence derived from the more distant VEEV relative, CHIKV. This was a 495 further evidence that VEEV SD1 is a critically important subdomain, which has been 496 specifically optimized for efficient virion assembly by independent evolution of the 497 different alphavirus species. Indeed, VEEV variants with chimeric capsid proteins rapidly 498 evolved and accumulated adaptive mutations in CHIKV and EEEV SD1 sequences. 499
Interestingly, compensatory mutations were found not only in SD1 itself, but also in SD2 500 (Helix I). VEEV with randomized SD1, VEEV/randSD1/GFP, developed the most 501 extensive modification in SD2. All of the detected mutations strongly increased the rates 502 of infectious virus release and indicated that SD1 and SD2 might synergistically function 503 in virus assembly. Indeed, combinations of CHIKV-derived SD1 and SD2 peptides in 504 VEEV/chikvSD12/GFP resulted in more efficient release of infectious virus particles 505 compared to VEEV/chikvSD1/GFP. VEEV/chikvSD12/GFP and 506 VEEV/chikvSD123/GFP variants replicate at higher rates and to higher titers than 507 VEEV/chikvSD1/GFP. 508
The results of the experiments with VEEV variants containing GFP in their capsid 509 protein also support the possibility that SD1 is critically involved in NC assembly and 510 virion building. GFP/capsid chimeric proteins strongly accumulated at the plasma 511 membrane and caused release of at least partially assembled particles, VLPs, only if they 512 contained the amino terminal SD1. Without this subdomain, the GFP/capsid protein was 513 diffusely distributed in the cytoplasm. 514
Cryo-EM reconstruction studies have previously described the existence of a 515 central core within NC (16). This core is thought to contain the first amino-terminal 516 residues of the capsid protein, corresponding to the SD1 and SD2 subdomains, and it was 517 suggested that its formation could initiate the rest of NC assembly. Thus, our functional 518 on July 14, 2017 by guest http://jvi.asm.org/ Downloaded from data support this structural model and suggest that SD1, in cooperation with SD2, plays a 519 crucial role in NC core assembly by mediating capsid multimerization, probably through 520 SD1-SD1 or SD1-SD2 interactions. They also support the hypothesis that the latter core 521 formation is critically important for the generation of both cytoplasmic NCs and those 522 formed at the plasma membrane at the places of virion budding. 523
As was expected based on published data (28, 29), no accumulation of the protein at the 524 plasma membrane was detected in the absence of glycoprotein expression, indicating that 525 capsid interaction with glycoprotein spikes is a critical driving force in particle formation. 526
Taken together, the accumulated data suggest the existence of a variety of capsid-527 specific checkpoints in the VEEV assembly process. They are summarized in concentrated by ultra-centrifugation as described in the Materials and Methods. Samples 679 were analyzed by Western blotting using VEEV-specific antibodies. Relative quantities 680
